MicroWash
MicroWash offers precise, painless COVID testing and diagnostics with its innovative specimen collection device.
- 1
- Private company
- Yutan, NE, USUnited States
MicroWash offers precise, painless COVID testing and diagnostics with its innovative specimen collection device.
getmicrowash.comCrawled Oct 14, 2026
The page compares PCR and antigen testing and presents MicroWash as a URI sampling solution.
Dr. Wadman discussed nasal sample sensitivity in MedCity News, comparing nasal swabs with evolved nasal lavage methods such as MicroWash and describing the benefits of representative samples across respiratory care.
Leading national media outlets recently tapped infectious disease expert Dr. Michael Wadman for hantavirus outbreak updates. The MicroWash CMO, who also serves as Medical Director of the National Quarantine Unit, shared insights on the facility's timely containment response.
Dr. Thanh Nguyen, the lead designer and developer behind MicroWash, authored an op-ed for Innovation & Tech Today exploring how his nearly two decades of emergency medicine experience continually inform his patient-first approach to medical device invention.
Developed by leading medical professionals at UMD, MicroWash replaces nasal swab collection, giving labs more reliable specimens & patients a better experience.
MicroWash’s sample collection system works with existing lab processes.
MicroWash is the first nasal lavage specimen collection device that delivers comfortable, fast & quality samples — surpassing the swab on virtually all levels.
The page is MicroWash’s website privacy policy, last updated March 1, 2024. MicroWash is owned and operated by University Medical Devices, Inc.
A respiratory care expert emphasizes **sample sensitivity** as a critical metric in diagnosing upper respiratory infections (URIs). The article highlights how sensitivity—the ability to accurately detect pathogens like flu, Covid-19, and RSV—directly impacts test reliability. Proper sample collection methods must prioritize this metric to improve diagnostic accuracy in clinical settings.
Jun 2026MedCity NewsNews article
Thanh Nguyen is profiled in the *Prairie Portraits* series, which highlights key figures in Nebraska’s innovation and entrepreneurship ecosystem. The feature spotlights founders, investors, and community leaders shaping the state’s startup landscape.
May 2026Silicon Prairie NewsNews article
Emerging research shows that diagnosing upper respiratory infections (URIs) within **96 hours** of symptom onset improves patient outcomes and reduces unnecessary healthcare escalation. Accurate early diagnosis enables faster treatment initiation, easing pressure on clinical workflows and operational demand. The timing of diagnosis critically influences both patient care and system efficiency in respiratory illness management.
Jan 2026MedCity NewsNews article
Evolved Nasal Lavage offers a potential alternative to traditional nasal swab testing, addressing public avoidance of URI tests post-pandemic. The discomfort and invasiveness of Covid-19 swabs created lasting test fatigue and reluctance among Americans. This method may help mitigate testing apprehension by providing a less intrusive option for respiratory illness detection.
Aug 2025MedCity NewsNews article